News: children with MS get their first licensed DMT

N
It may be old news, but it is very good news; the FDA has just licensed fingolimod as the first DMT for paediatric MS


I am sure parents of children with MS living in the US are relieved that they finally have a licensed therapy for their children. I sincerely hope the EMA now steps up to the mark and does the same in Europe.





As a reminder, the following are the headline results from the study that were presented at ECTRIMS last year. It is clear that fingolimod is far superior to interferon-beta in this younger population.




ProfG    








About the author

Prof G

Professor of Neurology, Barts & The London. MS & Preventive Neurology thinker, blogger, runner, vegetable gardener, husband, father, cook and wine & food lover.

5 comments

By Prof G

Translate

Categories

Recent Posts

Recent Comments

Archives